• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Rare Diseases

    Ruxoprubart Shows Best-in-Class Efficacy in PNH Phase II Trial

    GLOBENEWSWIRE

    FDA Grants NM5072 Orphan Status For PNH Treatment

    GLOBENEWSWIRE

    Ruxoprubart (NM8074) Scores FDA Orphan Drug Designation for PNH Treatment

    GLOBENEWSWIRE

    Anti-Bb Antibody Receives FDA Clearance to Start Trial in Naive aHUS Patients

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.